User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

1787

Interactions with Platform & by Email *

INTERACTIONS

322

Unique # Participated *

PARTICIPANTS

71

Responses Validated *

VALIDATIONS

16

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   A Prelude.....II-1
Market Opportunity.....II-1
Breast Cancer: A Common Malignancy Among Females in the Western World.....II-1
1$75
   Increased Instances of Breast Cancer in Younger Women!.....II-2
European Biopsy Devices Market.....II-2
Widespread Adoption of Advanced Diagnostic Systems Will Increase Demand for Breast
  Biopsy Devices.....II-2
1$75
   Key Statistics:.....II-3
Table 1: Worldwide Breast Cancer Incidence Rates & Mortality Rate (Per 100,000 persons) for the year 2007 (includes corresponding Graph/Chart).....II-3

Table 2: Percentage of Five-Year Survival Rate For Breast Cancer by Cancer Stage (includes corresponding Graph/Chart).....II-3
1$350
   Competitive Scenario:.....II-4
Current Market Conditions.....II-4
Impact of Recession.....II-4
Key Market Trends & Issues: A Review.....II-4
Continuous Fight Against Cancer: A Key Propeller for Growth.....II-4
1$75
   Population Aging Makes Rise Of Cancer Diagnostics Inevitable.....II-5
Table 3: Probability of Developing Breast Cancer by Age Group.....II-5

Table 4: Probability of Surviving Breast Cancer by Age Group (includes corresponding Graph/Chart).....II-5
1$350
   Table 5: Population Over 65 Years and Above in North America, Western Europe and Eastern Europe for the year 2007 (In Millions) (includes corresponding Graph/Chart).....II-6
Promising Developments in Breast Cancer Diagnosis Underway.....II-6
1$350
   Needle Biopsy Score Over Open Biopsy.....II-7
Widespread Awareness Among Patients & Practitioners: The Need of the Hour.....II-7
Rise in Use of Breast Markers.....II-7
1$75
   Rise in Use of MRI Guided Breast Biopsy.....II-8
Government Breast Cancer Screening Programs Drive Biopsy Devices Market.....II-8
Rise in Use of Single Insertion Breast Biopsy Needle.....II-8
Roll Out of Integrated Breast Centers.....II-8
1$75
   Vacuum-Assisted Biopsy Gain Physician Preference.....II-9
Table 6: Reimbursement Benefits for Vacuum-Assisted Over Core Needle Biopsy in Office Based Setting in the US Market for the year 2007.....II-9
1$350
   Reimbursement & Price Sensitivity: Key Challenges for Breast Biopsy Market.....II-10
Susceptibility to Radiation Exposure May Hinder Growth.....II-10
Competing Solutions May Limit Need of Breast Biopsy Procedures.....II-10
High Costs of Biopsy Markers May Constrain Growth.....II-10
1$75
   Pricing Factors.....II-11
Technology Innovations in Breast Care Management:.....II-11
Breast Thermography - An Alternative to Mammography.....II-11
Advanced MRI Technique May Limit Breast Biopsies in Women.....II-11
1$75
   Identification of New Genes May Improve Breast Cancer Diagnosis.....II-12
Innovative MRI Technique Identifies Cancerous Breast Tumors.....II-12
1$75
   Europe.....II-13
Market Overview.....II-13
Changing Physician Preferences Shape Breast Biopsy Market.....II-13
Market Restraints.....II-13
1$75
   Key Statistics:.....II-14
Table 7: Top Three Cancers Among Europeans for the year 2006 (includes corresponding Graph/Chart).....II-14
1$350
   Table 8: European Age-Standardised Rate (ASR) for Breast Cancer Incidence per 100, 000 Individuals, By Country, for the year 2006 (includes corresponding Graph/Chart).....II-151$350
   Table 9: European Age-Standardised Rate (ASR) for Breast Cancer Mortality per 100, 000 Individuals, By Country, for the year 2006 (includes corresponding Graph/Chart).....II-161$350
   Germany.....II-17
Italy.....II-17
1$75
   Table 10: Female Breast Cancer Cases in Italy (2005): Breakdown of Mortality, Incidence and Prevalence by Number of Cases for Key Italian Regions (includes corresponding Graph/Chart).....II-181$350
   United Kingdom.....II-19
Role of Government.....II-19
Key Statistics:.....II-19
Table 11: Percentage Share Breakdown of Common Causes of Female Cancer Deaths in the UK for the year 2007 (includes corresponding Graph/Chart).....II-19
1$350
   Table 12: Breakdown of New Breast Cancer Cases Diagnosed in the UK by Gender for the year 2006 (includes corresponding Graph/Chart).....II-20

Table 13: Breakdown of Breast Cancer Mortality in the UK by Gender for the year 2007 (includes corresponding Graph/Chart).....II-20
1$350
   Other Western Nations: Facts & Figures.....II-21
United States.....II-21
Key Statistics:.....II-21
Table 14: Breast Cancer in the United States: Breakdown of Incidence Rate By Ethnic Group for the year 2007.....II-21
1$350
   Table 15: Breast Cancer in the United States: Breakdown of Mortality Rate By Ethnic Group for the year 2007.....II-22

Table 16: Breakdown of Number of Breast Biopsy Procedures in the United States for the Years 2008 & 2013 (Number of Procedures in 000s) (includes corresponding Graph/Chart).....II-22

Table 17: US Breast Biopsy Devices Market (2008): Percentage Share Breakdown of Revenues by Key Players (includes corresponding Graph/Chart).....II-22
1$350
   Table 18: US Vaccuum-Assisted Breast Biopsy Disposables Market (2007): Percentage Share Breakdown of Revenues by Key Players (includes corresponding Graph/Chart).....II-23

Table 19: US Vaccuum-Assisted Biopsy Procedures (2007): Percentage Share Breakdown by Procedures Type (includes corresponding Graph/Chart).....II-23

Table 20: US Biopsy Products Market (2008): Percentage Share Breakdown of Revenues by Product Segment (includes corresponding Graph/Chart).....II-23
1$350
   Canada.....II-24
Table 21: New Breast Cancer-Related Diagnosis in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Incidence by Age Group (includes corresponding Graph/Chart).....II-24

Table 22: Breast Cancer-Related Deaths in Canada (2007): Percentage Share Breakdown of Female Breast Cancer Related Death by Age Group (includes corresponding Graph/Chart).....II-24
1$350
   Breast Cancer.....II-25
Risk Factors.....II-25
Breast Cancer Screening.....II-25
1$75
   Breast Cancer Diagnosis.....II-26
Breast Biopsy.....II-26
1$75
   Breast Biopsy Procedures.....II-271$75
   Surgical Biopsy.....II-28
Needle Biopsy.....II-28
Fine Needle Aspiration.....II-28
Core Needle Biopsy.....II-28
1$75
   Vacuum-Assisted Biopsy.....II-29
Commonly Used Breast Biopsy Devices.....II-29
Spring Loaded Biopsy Needle.....II-29
Vacuum-Assisted Core Biopsy Device.....II-29
Minimally Invasive Breast Biopsy (MIBB) Device.....II-29
1$75
   Advanced Breast Biopsy Instrumentation (ABBI) Device.....II-30
Mammotome.....II-30
Advances in Breast Imaging Techniques.....II-30
1$75
   Ultrasound Image Guidance.....II-31
Stereotactic Image Guidance.....II-31
Magnetic Resonance Imaging.....II-31
Mammotome® Breast Biopsy System.....II-31
1$75
   Digital Spot-View Mammography Enhances Breast Biopsy.....II-32
Biopsy Tissue Markers.....II-32
1$75
   Senorx Unveils New Model of Senosonix System.....II-33
SenoRx to Release StarchMark™.....II-33
SenoRx Unveils EnCor®.....II-33
Siemens Healthcare Launches New Biopsy Device.....II-33
1$75
   Terason Enters into Agreement with SenoRx.....II-34
SenoRx Receives CE Mark Rights for Contura™ MLB.....II-34
RevMed Inks a Global License with SPD.....II-34
1$75
   Sanarus Technologies Acquires Sanarus Medical.....II-35
Hologic Obtains CE Mark Approval for Celero®.....II-35
Echoserve, SenoRx Enter Into Co-Promotion Deal.....II-35
Naviscan Receives FDA’s Approval for Stereo Navigator™.....II-35
1$75
   Volcano Acquires Novelis.....II-36
SenoRx Receives CE Mark Approval for SenoSonix.....II-36
Hologic Completes Merger with Cytyc Corporation.....II-36
1$75
   C. R. Bard Inc. (USA).....II-37
Bard Biopsy Systems (USA).....II-37
Cardinal Health, Inc. (USA).....II-37
1$75
   Ethicon Endo-Surgery, Inc (USA).....II-38
GE Healthcare (UK).....II-38
Hologic, Inc. (USA).....II-38
1$75
   iCAD, Inc. (USA).....II-39
Intact Medical Corporation (USA).....II-39
Koninklijke Philips Electronics N.V. (The Netherlands).....II-39
Rubicor Medical, Inc., (USA).....II-39
1$75
   Sanarus Technologies, LLC (USA).....II-40
SenoRx, Inc (USA).....II-40
Siemens AG (Germany).....II-40
1$75
   Table 23: European Recent Past, Current & Future Analysis for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-411$350
   Table 24: European Historic Review for Breast Biopsy Devices with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-421$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com